[HTML][HTML] Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms

G Wallukat, B Hohberger, K Wenzel, J Fürst… - Journal of Translational …, 2021 - Elsevier
Impairment of health after overcoming the acute phase of COVID-19 is being observed more
and more frequently. Here different symptoms of neurological and/or cardiological origin …

[HTML][HTML] Dysregulated autoantibodies targeting vaso-and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity

F Sotzny, IS Filgueiras, C Kedor, H Freitag… - Frontiers in …, 2022 - frontiersin.org
Most patients with Post COVID Syndrome (PCS) present with a plethora of symptoms without
clear evidence of organ dysfunction. A subset of them fulfills diagnostic criteria of myalgic …

The autonomic aspects of the post-COVID19 syndrome

A Dotan, P David, D Arnheim, Y Shoenfeld - Autoimmunity reviews, 2022 - Elsevier
Abstract The SARS-CoV-2 outbreak, responsible for the widespread COVID-19, led to one of
the most rogue pandemics in modern time, yet the major effects of the pandemic may still be …

Overview of autoantibodies in COVID‐19 convalescents

K Dobrowolska, D Zarębska‐Michaluk… - Journal of medical …, 2023 - Wiley Online Library
Accumulating evidence shows that SARS‐CoV‐2 can potentially trigger autoimmune
processes, which can be responsible for the long‐term consequences of COVID‐19 …

Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection

B Hohberger, T Harrer, C Mardin, F Kruse… - Frontiers in …, 2021 - frontiersin.org
Clinical features of Coronavirus disease 2019 (COVID-19) are caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). Acute infection management is a …

[HTML][HTML] Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome

D Bertin, E Kaphan, S Weber, B Babacci… - International Journal of …, 2021 - Elsevier
Persistence of various symptoms in patients who have recovered from coronavirus disease
2019 (COVID-19) was recently defined as 'long COVID'or 'post-COVID syndrome'(PCS). This …

Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity

O Cabral-Marques, G Halpert, LF Schimke… - Nature …, 2022 - nature.com
COVID-19 shares the feature of autoantibody production with systemic autoimmune
diseases. In order to understand the role of these immune globulins in the pathogenesis of …

[HTML][HTML] Post-COVID syndrome: the aftershock of SARS-CoV-2

A Dotan, Y Shoenfeld - International Journal of Infectious Diseases, 2022 - Elsevier
Significant time has passed since the coronavirus disease of 2019 (COVID-19) pandemic
outbreak, which led to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

[HTML][HTML] Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19

JM Anaya, DM Monsalve, M Rojas, Y Rodríguez… - Journal of translational …, 2021 - Elsevier
Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2
infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid …

[HTML][HTML] High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms

C Franke, C Ferse, J Kreye, SM Reincke… - Brain, behavior, and …, 2021 - Elsevier
Background COVID-19 intensive care patients can present with neurological syndromes,
usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of …